Christophe Bourdon

Christophe Bourdon is an experienced executive with a robust background in the pharmaceutical and biopharmaceutical industries. Currently serving as a Management Board Member at Sobi since April 2023 and as CEO at LEO Pharma also since April 2022, Christophe has held several senior positions in leading companies. Notable roles include Chief Executive Officer at Orphazyme A/S, Senior Vice President and General Manager of U.S. Oncology at Amgen, and Senior Vice President at Alexion Pharmaceuticals. With a career foundation established at Sanofi and EADS, Christophe holds an MBA from IMD and a business degree from ISG Institut Supérieur de Gestion.